Auriacombe S

References (4)

Title : Symptomatic treatments in Alzheimer's disease in 2016: a study from Memory centers in France - Hommet_2016_Geriatr.Psychol.Neuropsychiatr.Vieil_14_274
Author(s) : Hommet C , Novella JL , Auriacombe S , Vercelletto M , Berrut G , Belliard S , Desmidt T , Ceccaldi M
Ref : Geriatr Psychol Neuropsychiatr Vieil , 14 :274 , 2016
Abstract :
PubMedSearch : Hommet_2016_Geriatr.Psychol.Neuropsychiatr.Vieil_14_274
PubMedID: 27651009

Title : Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment - Dantoine_2006_Int.J.Clin.Pract_60_110
Author(s) : Dantoine T , Auriacombe S , Sarazin M , Becker H , Pere JJ , Bourdeix I
Ref : Int J Clin Pract , 60 :110 , 2006
Abstract :
PubMedSearch : Dantoine_2006_Int.J.Clin.Pract_60_110
PubMedID: 16409439

Title : Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology - Burns_2006_J.Psychopharmacol_20_732
Author(s) : Burns A , O'Brien J , Auriacombe S , Ballard C , Broich K , Bullock R , Feldman H , Ford G , Knapp M , McCaddon A , Iliffe S , Jacova C , Jones R , Lennon S , McKeith I , Orgogozo JM , Purandare N , Richardson M , Ritchie C , Thomas A , Warner J , Wilcock G , Wilkinson D
Ref : J Psychopharmacol , 20 :732 , 2006
Abstract :
PubMedSearch : Burns_2006_J.Psychopharmacol_20_732
PubMedID: 17060346

Title : Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil - Auriacombe_2002_Curr.Med.Res.Opin_18_129
Author(s) : Auriacombe S , Pere JJ , Loria-Kanza Y , Vellas B
Ref : Curr Med Res Opin , 18 :129 , 2002
Abstract :
PubMedSearch : Auriacombe_2002_Curr.Med.Res.Opin_18_129
PubMedID: 12094822